Synthesis and Agonistic Activity at the GPR35 of 5,6-Dihydroxyindole-2-carboxylic Acid Analogues
摘要:
5,6-Dihydroxyindole-2-carboxylic acid (DHICA), an intermediate of melanin synthesis and an eumelanin building block, was recently discovered to be a GPR35 agonist with moderate potency. Here, we report the synthesis and pharmacological characterization of a series of DHICA analogues against GPR35 using both label-free, dynamic mass redistribution and Tango beta-arrestin translocation assays. This led to identification of novel GPR35 agonists with improved potency and/or having biased agonism.
[EN] GPR35 LIGANDS AND THE USES THEREOF<br/>[FR] LIGANDS DE GPR35 ET LEURS UTILISATIONS
申请人:CORNING INC
公开号:WO2013022740A2
公开(公告)日:2013-02-14
Disclosed are compositions and methods for reducing the risk of and/or treatment of diseases which are pathophysiologically related to GPR35, and/or GPR35-hERG signaling complex. For example, disclosed are compounds for reducing the risk of and/or treating diseases which are pathophysiologically related to GPR35 in a subject.